chronic hepatitis B

layoffs cuts workforce reduction chairs boxes fired
Biotech

Arbutus jettisons 57% of staff, ends in-house research

Arbutus is stripping its workforce back to just a “core team” needed to oversee mid-stage trials of its potential functional cure for hepatitis B.
James Waldron Mar 27, 2025 11:11am
hepatitis B virus

GSK drops 1 potential 'cure' for hep B, focuses on bepirovirsen

Feb 5, 2025 6:00am
A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune Tx's $175M series B to fund epigenetic HBV therapy's trials

Jan 13, 2025 8:23am
hepatitis B virus

GSK axes hepatitis B vaccine trial after missing efficacy goal

Dec 4, 2024 5:15am
A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune’s HBV therapy hits the right notes in cells and mice

Dec 7, 2023 2:05pm
The silhouette of a miner digging

Hepatitis B drug developers chart slow progress, just like hep C

Nov 14, 2023 9:05am